ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 162 filers reported holding ACORDA THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 2.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $102,000 | -54.7% | 110,300 | 0.0% | 0.05% | +107.7% |
Q4 2019 | $225,000 | -26.7% | 110,300 | +175.2% | 0.03% | +23.8% |
Q2 2019 | $307,000 | -93.6% | 40,084 | -88.9% | 0.02% | -90.6% |
Q1 2019 | $4,812,000 | -24.5% | 362,100 | -11.5% | 0.22% | -49.3% |
Q4 2018 | $6,376,000 | +1.3% | 409,300 | +27.7% | 0.44% | +22.2% |
Q3 2018 | $6,295,000 | -46.6% | 320,400 | -22.0% | 0.36% | -47.9% |
Q2 2018 | $11,795,000 | -2.7% | 411,000 | -19.8% | 0.69% | -10.7% |
Q1 2018 | $12,122,000 | +38.1% | 512,600 | +25.3% | 0.77% | +64.7% |
Q4 2017 | $8,775,000 | -18.9% | 409,100 | -10.6% | 0.47% | -19.0% |
Q3 2017 | $10,822,000 | +26.7% | 457,600 | +5.5% | 0.58% | +10.1% |
Q2 2017 | $8,543,000 | +111.1% | 433,700 | +125.1% | 0.53% | +105.9% |
Q1 2017 | $4,046,000 | -34.4% | 192,700 | -41.2% | 0.26% | -49.5% |
Q4 2016 | $6,164,000 | +1.0% | 327,900 | +12.1% | 0.51% | +2.4% |
Q3 2016 | $6,105,000 | -18.1% | 292,400 | 0.0% | 0.50% | -29.0% |
Q2 2016 | $7,457,000 | +5.1% | 292,400 | +9.0% | 0.70% | -2.8% |
Q1 2016 | $7,096,000 | +29.1% | 268,300 | +108.8% | 0.72% | +2.4% |
Q4 2015 | $5,497,000 | +92.3% | 128,500 | +19.1% | 0.70% | +88.7% |
Q3 2015 | $2,859,000 | -20.5% | 107,900 | 0.0% | 0.37% | -26.1% |
Q2 2015 | $3,595,000 | +21.7% | 107,900 | +21.5% | 0.50% | +21.5% |
Q1 2015 | $2,955,000 | -18.6% | 88,800 | 0.0% | 0.41% | -32.3% |
Q4 2014 | $3,629,000 | -6.6% | 88,800 | -22.6% | 0.61% | +4.5% |
Q3 2014 | $3,886,000 | -18.4% | 114,700 | -18.9% | 0.58% | -17.5% |
Q2 2014 | $4,765,000 | +82.0% | 141,400 | +104.6% | 0.71% | +74.0% |
Q1 2014 | $2,618,000 | +10.0% | 69,100 | -15.3% | 0.41% | -1.2% |
Q4 2013 | $2,381,000 | +2.9% | 81,600 | +20.7% | 0.41% | -22.1% |
Q3 2013 | $2,314,000 | -3.0% | 67,600 | -6.5% | 0.53% | -17.2% |
Q2 2013 | $2,385,000 | – | 72,300 | – | 0.64% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |